SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe, a prominent meme coin, is experiencing a surge of community chatter and speculative interest, with many anticipating significant price movements and a desire to "drop a zero." Despite some skepticism regarding its long-term utility, conversations are largely driven by a bullish "degen" mentality and comparisons to other top meme assets amidst notable market volatility.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is heavily trending following record-breaking December and fourth-quarter vehicle deliveries, which are significantly boosting investor optimism about its imminent milestone of one million cumulative cars and its projected path to profitability. The community is actively discussing whether these strong sales, particularly from its premium models and unique battery swap technology, will finally overcome persistent market skepticism and perceived manipulation to drive a substantial valuation rebound in 2026.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending with intense debate ahead of its upcoming Q4 delivery report and Elon Musk's latest update on Cybercab production slated for April 2026. Bulls anticipate better-than-expected deliveries and significant upside from autonomous driving, noting a prominent short seller recently covered positions. Conversely, bears remain highly skeptical, citing weakening EV demand and expressing doubts about the aggressive timelines for Robotaxi deployment, pushing concerns over the stock's elevated valuation.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is trending amidst strong community discussion surrounding its pivotal role as infrastructure for real-world asset (RWA) tokenization and bank integration. This comes as a Grayscale Spot ETF recently launched and its Cross-Chain Interoperability Protocol (CCIP) sees increasing adoption by major entities, driving optimism among holders and institutional observers.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is at the center of a heated debate as investors weigh cooler-than-expected CPI data against ongoing concerns about government spending and potential underlying inflationary pressures. While some anticipate a rally in long-duration bonds fueled by the Federal Reserve's rate cuts and new bond purchase program, a strong contingent expects long-term yields to remain elevated or rise further. The significant short interest reflects deep market divisions on whether economic slowdowns or persistent inflation will ultimately drive TLT's trajectory.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending amid high anticipation for a Department of Energy announcement regarding surplus plutonium allocation, which could provide crucial, low-cost fuel for its advanced reactors. The community is hotly debating whether this governmental support and significant de-risking will accelerate Oklo's commercialization to meet AI energy demands, balancing excitement against concerns over its pre-revenue status and recent insider selling.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending due to renewed speculative fervor around physical silver scarcity, driven by new Chinese export restrictions and robust industrial demand. The community is sharply divided, with bulls anticipating a massive short squeeze to $100+ amidst talk of bank long positions and divergence from paper prices, while bears warn of a pump-and-dump scheme and further declines following recent CME margin hikes. This ongoing debate highlights the battle between perceived physical supply constraints and market manipulation fears.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending following recent promising open-label data from its FLAMINGO-01 breast cancer trial, which has significantly de-risked the asset. This clinical optimism, amplified by management's extended insider share lock-ups, is driving strong community sentiment around a potential short squeeze due to high borrow costs and tight float. Investors are also actively discussing an impending buyout or partnership, viewing the company as undervalued given its potential in the HER2+ breast cancer market.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is currently trending with high volatility following news of a strategic manufacturing partnership to scale production of its drug screening reader, alongside a significant private placement. While bullish investors view the capital infusion and increased production as catalysts for growth and future market expansion, a strong opposing sentiment is debating the dilutive impact of the share issuance and warrants, suggesting a potential price decline given the stock's recent reverse split and low-float trading characteristics.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is facing a significant sell-off after the FDA issued a Complete Response Letter for its relacorilant drug, citing a need for additional efficacy evidence. The community is actively debating whether the steep decline is an overreaction, emphasizing the company's established revenue stream from an approved drug and a robust pipeline that includes an eagerly awaited ovarian cancer drug decision and a pending patent lawsuit ruling. Many investors are viewing the current valuation as a compelling long-term buying opportunity despite the regulatory hurdle.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
